Peptide influencers with discount codes: what the science says

What did @fitunc actually say?

The creator listed three "worst side effects" of peptides: anhedonia from GLP-1 receptor agonists (called "RETA," likely referencing semaglutide or similar), a cancer diagnosis allegedly linked to melanotan use, and the broad unknown of long-term risks. The framing was more moral lecture than health information. The word "pathetic" appeared. So did "bruh."

To be fair, the creator is not selling anything here. They are explicitly calling out influencers with discount codes in their bios, which is a legitimate concern in a space saturated with financially motivated promotion. The critique of unknown long-term risks is genuinely valid. But several specific claims range from oversimplified to outright unverifiable, and the confident causal language around cancer is a problem.

Does the science back this up?

Partially, and it depends heavily on which claim you are examining. The anhedonia point has some real grounding. The cancer claim does not have credible evidence behind it as stated. The unknown-risks argument is probably the most defensible of the three.

On anhedonia: GLP-1 receptor agonists do appear to modulate dopamine pathways. A 2023 paper by Blum et al. in the Journal of Personalized Medicine explored GLP-1 receptor activity in reward circuitry, and there are accumulating case reports of reduced motivation and emotional blunting in patients on semaglutide. The FDA added new safety information in 2024 related to suicidal ideation signals being monitored. That said, "you're literally altering your brain chemistry in an insane way" is not a clinical description. Many medications alter brain chemistry. That is often the point.

On melanotan and cancer: Melanotan II (MT-II) is an unregulated synthetic peptide analog of alpha-MSH. It activates melanocortin receptors and increases skin pigmentation and libido. There are documented case reports of melanoma-like lesions and changes to existing moles following MT-II use, including a 2014 case series by Nguyen et al. in JAMA Dermatology. But "definitively looking like it was caused by" a TikTok post about someone's cancer is not science. That framing should have stayed in the drafts.

What did they get wrong (or right)?

They got the concern about melanotan right but the causation claim wrong. MT-II is genuinely risky and unregulated. However, saying a cancer diagnosis is "definitively" linked to MT-II based on TikTok comments is not how causation works in medicine or anywhere else. That is anecdote dressed up as evidence, and it deserves to be called out directly.

The anhedonia framing is an oversimplification but not baseless. The specific concern that GLP-1 drugs affect dopamine and reward signaling is supported in emerging literature. What the creator misses is that anhedonia is also a symptom of obesity itself, and separating drug effect from baseline condition is genuinely difficult in this population. Researchers like Volkow et al. (2011, Biological Psychiatry) have documented dopaminergic deficits in obesity independent of any drug use.

The "unknown risks" point is the strongest argument here, and the creator deserves credit for making it. Peptides like BPC-157, TB-500, and various growth hormone secretagogues lack long-term human trial data. Enthusiasm in online communities has outpaced the clinical literature by a significant margin.

What should you actually know?

Three things matter here. First, "peptides" is not one category. GLP-1 agonists, melanotan analogs, and healing peptides like BPC-157 have entirely different mechanisms, risk profiles, and regulatory statuses. Grouping them into a single side-effect list is like grouping aspirin, ketamine, and testosterone together.

Second, the regulatory context is real. The FDA has not approved most peptides discussed in fitness communities for the indications people are using them for. Compounded peptides operate in a gray zone that is narrowing. The risk is not just biological, it is also legal and quality-control related. Unregulated sources mean unknown purity and dosing.

Third, the creator's overall instinct, that people are taking on unknown risks for appearance and performance goals, is not wrong. But framing it as laziness versus willpower misses the actual clinical complexity and does not help anyone make a better-informed decision.